MSI2 and neoplasm: To further substantiate the increased MSI2 gene and protein in NSCLC patients, we analyzed and confirmed the high MSI2 expression in matched tumor and normal tissues obtained from LUSC and LUAD patients (GSE31552) (Fig. 1E).